methyl 5-chloro-3-(methylsulfamoyl)thiophene-2-carboxylate

We are methyl 5-chloro-3-(methylsulfamoyl)thiophene-2-carboxylate CAS:70374-37-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:methyl 5-chloro-3-(methylsulfamoyl)thiophene-2-carboxylate
CAS.NO:70374-37-7
Synonyms:methyl 5-chloro-3-(methylsulfamoyl)thiophene-2-carboxylate
Methyl5-chloro-3-chlorosulfonyl-2-thiophenecarboxylate
METHYL 5-CHLORO-3-[(METHYLAMINO)SULFONYL]-THIOPHENE-2-CARBOXYLATE
Methyl 5-chloro-3-(N-methylsulfamoyl)thiophene-2-carboxylate
 
Physical and Chemical Properties:
Density 1.5±0.1 g/cm3
Boiling Point 424.6±55.0 °C at 760 mmHg
Molecular Formula C7H8ClNO4S2
Molecular Weight 269.726
Flash Point 210.6±31.5 °C
Vapour Pressure 0.0±1.0 mmHg at 25°C
Index of Refraction 1.559
 
Specification:
Appearance:Almost white powder
Assay(HPLC):≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Lornoxicam(CAS:70374-39-9).

methyl 5-chloro-3-(methylsulfamoyl)thiophene-2-carboxylate


Related News: It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance.831-82-3 The upstream of pharmaceutical intermediates is the basic chemical raw material industry. Basic chemical raw materials are bulk commodities and prices fluctuate greatly, which directly affects the production costs of enterprises.2-(2-methoxyethoxy)-N-(oxomethylidene) Catalent, a global leader in clinical supply services, recently announced the launch of its new CTSuccessTM clinical trial planning service, designed to support trial sponsors with earlier, more proactive and robust clinical supply chain planning, and reduce the risk of delays and budget overspend common to clinical trials as they progress.3,4-dicloroanilina CAS:95-76-1 Catalent, a global leader in clinical supply services, recently announced the launch of its new CTSuccessTM clinical trial planning service, designed to support trial sponsors with earlier, more proactive and robust clinical supply chain planning, and reduce the risk of delays and budget overspend common to clinical trials as they progress.As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.

Related Products
Product Name
1-Naphthylboronic Acid View Details
(2-fluorophenyl)-(4-fluorophenyl)methanone View Details
(S)-1,2,3,4-Tetrahydro-1-Naphthoic Acid View Details
CAS:31923-86-1 UNIOL PB-700 manufacturer N-(4-methylpentan-2-ylidene)hydroxylamine manufacturer 2-Bromo-5-nitrobenzotrifluoride manufacturer 3-Chloro-4-fluorobenzaldehyde manufacturer N-(2-Methyl-5-Nitrophenyl)-4-(Pyridin-3-yl)Pyrimidin-2-Amine manufacturer